High-grade human brain tumors exhibit increased expression of myelin transcription factor 1 (MYT1), a zinc finger DNA-binding protein

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 7, 1997, Pages 772-781

  Armstrong, Regina C ^a   Migneault, Alain ^a   Shegog, Marya L ^a   Kim, Jin G ^b   Hudson, Lynn D ^b   Hessler, Richard B ^c,d  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Astrocytoma; Dysembryoplastic neuroepithelial tumor; Glioma; Nuclear structure; Oligodendrocyte; Oligodendroglioma; Transcription factor

Indexed keywords

DNA BINDING PROTEIN; MONOCLONAL ANTIBODY KI 67; MYELIN TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ADULT; ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; CASE REPORT; CELL PROLIFERATION; GLIA CELL; HUMAN; HUMAN TISSUE; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; REVIEW;

EID: 0031000401     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199756070-00003     Document Type: Review

References (36)

1. Sung CC, Collins R, Li J, et al. Glycolipids and myelin proteins in human oligodendrogliomas. Glycoconjugate J 1996;13:433-43
2. Tenenbaum L, Teugels E, Dogusan Z, Avellana-Adalid V, Hooghe-Peters EL. Plastic phenotype of human oligodendroglial tumor cells in vitro. Neuropath Appl Neurobiol 1996;22:302-10
3. Kim JG, Hudson LD. Novel member of the zinc finger superfamily: A C2-HC finger that recognizes a glia-specific gene. Mol Cell Biol 1992;12:5632-39
4. Armstrong RC, Kim JG, Hudson LD. Expression of myelin transcription factor I (MYT1), a "zinc-finger" DNA-binding protein, in developing oligodendrocytes. Glia 1995;14:303-21
5. Armstrong RC, Dorn HH, Kufta CV, Friedman E, Dubois-Dalcq ME. Pre-oligodendrocytes from adult human CNS. J Neurosci 1992;12:1538-47
6. Gogate N, Verma L, Zhou JM, et al. Plasticity in the adult human oligodendrocyte lineage. J Neurosci 1994;14:4571-87
7. Weiss S, Reynolds BA, Vescovi AL, Morshead C, Craig CG, van der Kooy D. Is there a neural stem cell in the mammalian forebrain? Trends in Neurosci 1996;19:387-93
8. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas: A simple and reproducible method. Cancer 1988;62:2152-65
9. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumors of the central nervous system. Berlin: Springer-Verlag, 1993
10. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumors. Brain Pathol 1993;3:255-68
11. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-15
12. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Path 1991;138:867-73
13. Daumas-Duport C, Scheithauer BW, Chodkiewicz J-P, Laws ER, Vedrenne C. Dysembryoplastic neuroepithelial tumor: A surgically curable tumor of young patients with intractable partial seizures. Neurosurg. 1988;23:545-56
14. Hirato J, Nakazato Y, Ogawa A. Expression of non-glial intermediate filament proteins in gliomas. Clin Neuropath 1994;13:1-11
15. Lopes MBS, Vandenberg SR, Scheithauer BW. The pathology of oligodendrogliomas. In: Apusso MLJ, ed. Benign cerebral glioma, vol 1. Neurosurgical topics. AAANS Publications Committee, 1995
16. Revesz T, Scaravilli F, Coutinho L, Cockburn H, Sacares P, Thomas DGT. Reliability of histological diagnosis including grading in gliomas biopsied by image-guided stereotactic technique. Brain 1993;116:781-93
17. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T. Ki-67 immunoreactivity in human central nervous system tumors: A study with MIB 1 monoclonal antibody on archival material. Acta Neuropath 1994;87:47-54
18. Ellison DW, Steart PV, Bateman AC, Pickering RM, Palmer JD, Weller RO. Prognostic indicatiors in a range of astrocytic tumours: An immunohistochemical study with Ki-67 and p53 antibodies. J Neurol Neurosurg Psychiatry 1995;59:413-19
19. Gensert JM, Goldman JE. In vivo characterization of endogenous proliferating cells in adult subcortical white matter. Glia 1996;17:39-51
20. Hart IK, Richardson WD, Heldin CH, Westermark B, Raff MC. PDGF receptors on cells of the oligodendroctye-type-2 astrocyte (O-2A) cell lineage. Development 1989;105:595-603
21. McKinnon RD, Matsui T, Dubois-Dalcq M, Aarsonson SA. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 1990;5:603-14
22. Bellefroid EJ, Bourguignon C, Hollemann T, Ma Q, Anderson DJ, Kintner C, Pieler T. X-MyT1, a Xenopus C2HC-type zinc finger protein with a regulatory function in neuronal differentiation. Cell 1996;87:1191-1202
23. Prayson RA, Estes ML, Morris HH. Coexistence of neoplastia and cortical dysplasia in patients presenting with seizures. Epilepsia 1993;34:609-615
24. Hirose T, Scheithauer BW, Lopes BS, Vandenberg SR. Dysembryoplastic neuroepithelial tumor (DNT): An immunohistochemical and ultrastructural study. J Neuropath Exp Neurol 1994;53:184-95
25. Wolf HK, Wellmer J, Muller MB, Wiestler OD, Hufnagel A, Pietsch T. Glioneuronal malformative lesions and dysembryoplastic neuroepithelial tumors in patients with chronic pharmacoresistant epilepsies. J Neuropath Exp Neurol 1995;54:245-54
26. Mapstone TB. Expression of platelet-derived growth factor and transforming growth factor and their correlation with cellular morphology in glial tumors. J Neurosurg 1991;75:447-51
27. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin C-H, Westermark B, Nister M. Platelet-derived growth factor and its receptor in human glioma tissue: Expression of messenger RNA and protein suggest the presence of autocrine and paracrine loops. Cancer Res 1992;52:3213-19
28. Paulus W, Grothe C, Sensenbrenner M, Janet T, Baur I, Graf M, Roggendorf W. Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumors. Acta Neuropath 1990;79:418-23
29. Bogler O, Wren D, Barnett SC, Land H, Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci USA 1990;87:6368-72
30. Schmitz ML, Henkel T, Baeuerle PA. Proteins controlling the nuclear uptake of NF-κB, Rel and dorsal. Trends Cell Biol 1991;1:130-37
31. Desbois C, Rousset R, Bantignies F, Jalinot P. Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein. Science 1996;273:951-53
32. Dyck JA, Maul GG, Miller WH, Chen JD, Kakizuka A, Evans RM. A novel macromolecular structure is a target of the promyelocyte retinoic acid receptor oncoprotein. Cell 1994;76:333-43
33. Weis K, Rambaud S, Lavau C, et al. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 1994;76:345-56
34. Freemont PS, Hanson IM, Trowsdale J. A novel cysteine-rich sequence motif. Cell 1991;64:483-84
35. Dent AL, Yewdell J, Puvion-Dutilleul F, Koken MHM, de The H, Staudt LM. LYSP100-associated nuclear domains (LANDS): Description of a new class of subnuclear structures and their relationship to PML nuclear bodies. Blood 1996;88:1423-36
36. Terris B, Baldin V, Dubois S, et al. PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res 1995;55:1590-97